Jan 12, 2026 07:01AM
Jan 12, 2026 07:00AM
Dec 17, 2025 04:05PM
Nov 5, 2025 07:36AM
Oct 8, 2025 06:46AM
Oct 7, 2025 06:01AM
Oct 7, 2025 06:00AM Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
Aug 14, 2025 07:30AM
Jul 7, 2025 07:37AM
Jul 7, 2025 07:01AM
Jul 7, 2025 07:00AM
Jun 5, 2025 12:44PM
May 12, 2025 07:00AM
Apr 8, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
Apr 7, 2025 06:22AM
Apr 7, 2025 06:00AM
Mar 26, 2025 06:50AM
Mar 24, 2025 07:00AM
Nov 14, 2024 06:59AM
Nov 13, 2024 07:30AM
Oct 30, 2024 06:16AM Lexeo Therapeutics (LXEO) Reports Positive Interim Data for LX1001
Oct 30, 2024 06:14AM
Oct 22, 2024 07:30AM
Aug 16, 2024 05:30AM
Aug 12, 2024 07:00AM
Jul 15, 2024 07:39AM
Jul 15, 2024 06:02AM
Jul 15, 2024 06:00AM Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
May 9, 2024 07:00AM
Apr 22, 2024 07:30AM
Apr 22, 2024 07:30AM
Apr 16, 2024 07:30AM
Apr 16, 2024 07:30AM
Mar 11, 2024 07:42AM
Feb 5, 2024 07:00AM Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
Dec 18, 2023 07:04AM
Dec 18, 2023 07:00AM
Dec 11, 2023 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All